David R. Bauer
Lawyers
Filters
TScan Therapeutics $150 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
Intra-Cellular Therapies $500 million stock offering
The shares are listed on the Nasdaq Global Select Market
Nurix Therapeutics $175 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
Ultra Clean Holdings $500 million term loan facilities and related amendments
We advised the borrower on the transaction
Arrow Electronics $500 million senior notes offering
The 5.875% investment-grade senior notes are due 2034
Biodesix $55 million follow-on offering
The common stock is listed on the Nasdaq Global Market
Stoke Therapeutics $125 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Select Market
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
MicroStrategy $603.75 million convertible notes offering
The convertible notes are due 2031
REGENXBIO $140 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market